Our Board

Primary Health Tasmania is governed by a skills-based Board of up to nine directors, six of which are elected by our members and three of which are appointed by the Board to address any skills gaps or strategic skill requirements.

The Primary Health Tasmania Board provides leadership and corporate governance oversight for the organisation.

Our Board committees

The Board delegates to and seeks advice from an advisory structure including:

  • Clinical Advisory Council
  • Community Advisory Council
  • Audit and Risk Advisory Committee
  • Finance Advisory Committee
  • Governance Advisory Committee.

Our Board directors

Dr Katrena Stephenson, Chair

BSc GradDipEnvStudies (Hons), PhD (Health Sociology), FAICD FLGP
Director since 2022, appointed second term to 2028

Katrena has 20 years of management experience including as CEO of the Local Government Association of Tasmania and Director for Environment, Development and Community at Kingborough Council. Before entering local government she held operational, policy and evaluation roles in a number of Tasmanian Government departments and also in the United Kingdom. Katrena’s skills have been applied in addressing key social determinants of health consistently across her career, including in youth health; as the architect of Tasmania’s first affordable housing strategy; in managing social projects within the Department of Premier and Cabinet; and in promoting and supporting local government’s role in health and wellbeing. Katrena is a graduate and Fellow of the Australian Institute of Company Directors (AICD) and in addition to her role on the Primary Health Tasmania Board, she is President of the AICD Tasmanian Divisional Council and Chair of TasWaste South. Other recent Board experience includes member of the Tasmanian Board of the Medical Board of Australia, Deputy President of Local Government Professionals, member of the Municipal Association of Victoria (MAV) Insurance Board, and Vice President of the Kingston Neighbourhood House. Katrena won the 2019 Tasmanian Telstra Businesswomen of the Year – Public Sector and Academia category and represented Tasmania in the national finals.

Mr Scott Adams

BCom, FCPA, MBA, EMPA, GAICD
Director since 2021, appointed second term to 2026

Scott has over 25 years of management experience in a range of corporate services including finance, human resources, risk management, ICT, project delivery and asset management. This includes senior roles with Aurora Energy, the Tasmanian Health Service and TasTAFE and Southern Cross Care. He is currently Chief Financial Officer with the Hobart City Mission. Scott brings extensive skills in managing relationships with both state and federal governments, as both a recipient of funding and a service provider, as well as a broad range of community stakeholders. As a graduate of the Australian Institute of Company Directors, Scott’s governance roles include Chairman, Treasurer and Director across seven not-for-profit organisations in diverse areas including child care, micro-credit schemes, regulation and cancer support services. With an interest in improving the patient experience of health, Scott held a non-executive director role with the newly formed Health Consumers Tasmania in order to continue to contribute to positive health outcomes. He is a passionate believer in patient-centred care and ensuring all areas of our health system, both primary and acute sectors, are working collaboratively to benefit the community.

Yvette Cehtel

LLB (UTAS), Graduate Certificate in Legal Practice (UTAS), LLM (Monash), GAICD, Harvard Executive Leadership Certificate
Director since 2025, elected first term to 2028

Connie Digolis

GC-PUBHL, GAICD
Director since 2025, elected first term to 2028

Dr Miranda Hann

MBBS, FRACGP
Director since 2024, elected first term to 2027

Dr Miranda Hann is a GP specialist working in Hobart, after graduating from the University of Queensland Ochsner in 2017. Miranda specialises in LGBTIQA+ health care. She is currently on the board of Working it Out, Tasmania’s sexuality, gender and intersex status support and education service. She sits on both government and healthcare committees for LGBTIQA+ advocacy and healthcare equality and is a guest lecturer for the University of Tasmania School of Medicine. She regularly speaks at parliament to improve healthcare access for LGBTIQA+ Tasmanians. Through her advocacy in working with historically marginalised groups, she is passionate about improving healthcare access for all Tasmanians, recognising that if you can serve those most discriminated against within our healthcare system, you can create a far more efficient and effective system for the entire community. She believes that if you improve the primary care outcomes for a patient, you not only drastically improve their life and health outcomes, but also the impact on our overburdened tertiary health centres. Miranda has received a multitude of awards for her work and advocacy in LGBTIQA+ health care in Tasmania, including Medicare Champion 2024 under the Stronger Medicare Awards, Ochre Tasmanian Doctor of the Year 2024, and the Royal Australian College of General Practitioners (RACGP)’s Tasmanian GP Registrar of the Year 2022.

Dr Tim Jones

MBBS, DCH (Westmead), FRACGP-RG, CCCH
Director since 2024, elected first term to 2027

Tim is a Hobart-based GP, rural generalist, supervisor, medical educator, mentor and advocate. He is deeply motivated to support our Tasmanian community, address health inequity in our most vulnerable, and build collaborative partnerships across the primary care sector. He works as a clinical GP with extended scope in paediatrics, psychological medicine, and allergy medicine. He works across primary care education in various roles and has a passion for supporting the next generation of our health workforce. Tim currently serves as the Specific Interest Chair of Child and Young Person’s Health for the Royal Australian College of General Practitioners (RACGP), and as the Deputy Chair of RACGP Tasmania. Tim takes professional pride in leadership that is personal, curious, collaborative and altruistic. He knows that a robust, dynamic and cohesive primary care sector is the cornerstone of a healthy population.

Dr Ginita Oberoi

MBBS FRACGP
Director since 2022, appointed second term to 2026

Ginita is a GP and practice partner in north west Tasmania. In what initially started as a short term ‘sea-change’ for a junior doctor, she has now cemented a career dedicated to rural and remote general practice. Ginita is also involved in supporting and training junior doctors and GPs and those who are new to general practice – she has held roles with the Post Graduate Medical Council of Tasmania and General Practice Training Tasmania. She has experience representing general practice on advisory committees for state projects and professional association committees such as the Royal Australian College of General Practitioners (RACGP) Tasmania’s New Fellows Committee to 2020. She is passionate about delivering the best health and wellbeing outcomes for her community and that investing in primary care is an imperative for a healthier Tasmania.

Distinguished Prof Greg Peterson

BPharm(Hons), PhD, MBA, FSHP, FACP, FPS, GAICD, AACPA, ARPharmS
Director since 2018, elected third term to 2027

Greg has worked in the primary healthcare sector for over 30 years, and continues to split his time between the University of Tasmania, where he is distinguished professor of pharmacy, and a suburban pharmacy he co-owns. He brings to the Board extensive management, governance, health systems improvement and entrepreneurial expertise. Over many years, he has taught within medical, nursing, paramedicine and pharmacy courses, along with clinical redesign and health service improvement. Greg has over 670 papers published in refereed international and national journals, plus research funding of over $60 million as Chief Investigator. Greg is Chair of the Cancer Council Tasmania and Director of Cancer Council Australia. He is a member of the Australian Government committee responsible for deciding which medicines should be listed on the Repatriation Pharmaceutical Benefits Scheme.